Retatrutide in Australia: A Potential Hope for Obesity Management ?
Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist , representing a significant advance in addressing excess weight. Early clinical trials have demonstrated impressive results, showing greater efficacy than existing treatments like semagluti